Previous meta-analyses have shown that serum levels of interleukin-1β, (IL1β), IL6, and tumour necrosis factor α (TNFα) are higher in AD compared to healthy controls (HC) and MCP-1 is higher in MCI compared to HC (Lai et al., 2017; Su et al., 2019). Here, IL6 is linked to Alzheimer disease.